| Document |
Document Title |
|
WO/2024/041031A1 |
The present invention relates to a bacterial continuous evolution system, an orthogonal error-prone DNA polymerase, and a continuous evolution method. According to the present invention, after an orthogonal DNA replication system is comb...
|
|
WO/2024/042238A2 |
Provided herein are a biological sorbent reagent for extracting a metal from a solution comprising the metal, comprising one or more of a Mucoromycota fungus and a prepared or processed biomass of the Mucoromycota fungus, a biological so...
|
|
WO/2024/042225A1 |
The invention relates to a method for separating the components of assemblies containing solder by oxidizing Fe(II) to Fe(III) by means of at least one Fe(II)-oxidizing microorganism and by at least partially leaching solder, wherein Fe(...
|
|
WO/2024/040345A1 |
A DNA fragment for facilitating the transfer of a plasmid transferable ("transferable plasmid") by conjugation from a donor bacterium to a recipient eukaryotic cell, the DNA fragment comprising a mutated traJ promoter operatively linked ...
|
|
WO/2024/043203A1 |
The present invention provides any of modified esterases of (i) to (iii) below. (i) A modified esterase including an amino acid sequence in which at least one amino acid at a site selected from the group consisting of (1) to (5) below ...
|
|
WO/2024/039859A1 |
A method of collecting fungal spores includes steps of producing fungal spores by fungal cells within a fungal culture; combining a hydrophobic liquid with the fungal culture; mixing the fungal culture after the step of combining the hyd...
|
|
WO/2024/037131A1 |
An organic solid-state fermentation enzyme formulation and an organic plant protease hydrolysate, and preparation methods therefor. The organic solid-state fermentation enzyme formulation is prepared by solid-state fermentation of protea...
|
|
WO/2024/038903A1 |
There is a problem in the supply of ovothiol A and related substances. The present disclosure provides a method for manufacturing ovothiol A or a related substance. This method for manufacturing ovothiol A or a related substance or a m...
|
|
WO/2024/037604A1 |
Provided are a Mycobacterium sp., a method for isolating same, and use thereof. The preservation number of the Mycobacterium sp. is CGMCC No. 21272 or CGMCC No. 21273. The Mycobacteria sp. has significant nitrogen fixation, carbon fixati...
|
|
WO/2024/037192A1 |
Provided a strain of Rhodotorula capable of efficiently degrading ethyl carbamate and use thereof. The present invention pertains to the technical field of food biology. Provided is a Rhodotorula strain DL-XSY01, which is capable of effi...
|
|
WO/2024/039163A1 |
The present invention relates to a novel Schizochytrium sp. strain containing a high protein content, antioxidant pigments and omega-3 fatty acids, and a method for producing a biomass containing a high protein content, antioxidant pigme...
|
|
WO/2024/039254A1 |
The vaccine disclosed herein enhances the growth parameters of Brassicaceae plants and can be used for biotization of Brassicaceae plants and for production of fully developed plant seedlings, e.g. for their direct sale.
|
|
WO/2024/039229A1 |
The present invention relates to: novel lactic acid bacteria, Lactococcus lactis P32 (KCCM13222P) and Bifidobacterium bifidum P45 (KCCM13223P), or a mixture thereof; and uses thereof. Strains and a mixture thereof, according to the prese...
|
|
WO/2024/037588A1 |
Provided are a Weizmannia coagulans capable of inhibiting the activity of alpha-glucosidase and/or alpha-amylase and use thereof. A Weizmannia coagulans SA9 strain is preserved in Guangdong Microbial Culture Collection Center on June 6, ...
|
|
WO/2024/038461A1 |
A vaccine is disclosed which compises a pharmaceutically acceptable carrier and Gramnegative bacteria, genetically modified to express: at least one disease-associated antigen, linked to a signal sequence belonging to a type II secretion...
|
|
WO/2024/036508A1 |
Provided are a fusion protease, a fusion expression vector, an engineered bacterium, and a method for producing N-acetylneuraminic acid. The fusion protease comprises N-acetyl-D-glucosamine 2-epimerase (AGE), N-acetylneuraminic acid aldo...
|
|
WO/2024/038893A1 |
Provided is a vial rack, which has a massive portion made of a metal having good thermal conductivity as the main body, to be applied to a gas-cooling type freezer. The massive portion of the vial rack has one or more holes for inserting...
|
|
WO/2024/038980A1 |
The present invention relates to Lactobacillus plantarum KU15120 strain and a use thereof. The (Lactobacillus plantarum KU15120 strain was found to have antioxidative and anti-obese effects, which led to the present invention.
|
|
WO/2024/037390A1 |
A strain of Lactobacillus rhamnosus and a composition comprising the Lactobacillus rhamnosus for inhibiting H. pylori. The composition further comprises hyaluronic acid or a salt thereof. The composition can significantly reduce the colo...
|
|
WO/2024/039850A1 |
A method of producing fungal spores utilizing solid-state fermentation (SSF), the method including steps of combining, in a solid-state fermentation vessel, fungal spores and a solid substrate to produce a fungal culture; subjecting the ...
|
|
WO/2024/038839A1 |
The present disclosure relates to a method for producing an immunoglobulin using a filamentous fungus, a filamentous fungus usable in this method, and a method for producing the filamentous fungus. More specifically, the present disclosu...
|
|
WO/2024/038466A1 |
Disclosed are a biological medium composition and an assay for antimicrobial susceptibility testing. The medium composition and the assay of the present invention that uses the said medium composition conserve the enzymomimetic activity ...
|
|
WO/2024/032467A1 |
Disclosed in the present invention are a high-stability recombinant collagen, and a construction method therefor and the use thereof. On the basis of an original collagen sequence, one or more mutations selected from a group consisting o...
|
|
WO/2024/035941A1 |
Coated crossflow filter membranes, crossflow filters comprising the coated filter membranes and crossflow filtration systems for separating material such as biological material sensitive to temperature, dissolved gases, and mechanical da...
|
|
WO/2024/032012A1 |
Provided are a phenylalanine ammonia lyase mutant, an encoding gene thereof, a genetically engineered microorganism, and a method for preparing the phenylalanine ammonia lyase mutant. Also provided is use of the phenylalanine ammonia lya...
|
|
WO/2024/034365A1 |
The present invention relates to a medium or medium additive which is for cultivating edible mushrooms of the family Lyophyllaceae or Physalacriaceae, and which contains D-alanine as a nutrient source. The medium or the medium additive m...
|
|
WO/2024/035661A1 |
This disclosure provides for an improved method of stabilizing spray-dried bacterial extracts with a composition comprising a stabilizer such that the extracts can be used in cell-free protein synthesis. Also provided herein are formulat...
|
|
WO/2024/036328A2 |
Disclosed are recombinant bacteria (e.g., Citrobacter) for producing cationic biological polysaccharide flocculant, and applications of using them. Sequence(s) encoding ribulose carboxylase 1,5-bisphosphate, ribulose phosphorylase, and a...
|
|
WO/2024/036189A2 |
Disclosed herein is a yeast strain capable of fermenting corn mash into ethanol with no exogenous glucoamylase resulting in greater speed and efficiency than the leading industrial strain. Said yeast strain causes enhanced polysaccharide...
|
|
WO/2024/031174A1 |
A process to increase the amount of methane produced from a bio-digester, said method comprising the steps of: - providing a digester adapted to receive a feed and capture a biogas composition resulting from biodigestion; - adding to sai...
|
|
WO/2024/036155A2 |
Described herein are split recombinases having inducible recombinase activity and polynucleic acid molecules encoding the same. Also described herein are kits and host cells comprising the split recombinases, as well as methods of their ...
|
|
WO/2024/032822A1 |
The present invention relates to an improved antibody specifically binding to amyloid-β oligomers (AβOs). Specifically, the present invention relates to an improved form of a W20 antibody. Compared with the W20 antibody, the improved f...
|
|
WO/2024/032452A1 |
Provided is a Lactiplantibacillus plantarum 1-D1 strain and a use thereof. The strain features genetic stability, no pathogenic/virulent genes, good safety and strong antimicrobial ability to pathogenic microorganisms, and can reduce vag...
|
|
WO/2024/034631A1 |
The present invention is a modified fibroin that contains a domain sequence represented by formula 1: [(A)n motif-REP]m or formula 2: [(A)n motif-REP]m-(A)n motif and has a GQ motif content of 12.5% or less. (In formulae 1 and 2, (A)n mo...
|
|
WO/2024/034638A1 |
The present invention pertains to: an antibody which binds to FGF23 and in which, with respect to an antibody that includes a heavy chain variable region (hereinafter, referred to as VH) having an amino acid sequence indicated in SEQ ID ...
|
|
WO/2024/034619A1 |
According to an embodiment, the present disclosure provides a modified luciferase having improved luminescence intensity, and a use thereof. The present disclosure relates to a modified luciferase derived from a luminous mushroom, or a...
|
|
WO/2024/034576A1 |
This method for culturing a cancer organoid includes culturing the cancer organoid on the top surface or inside of a cell structure in a medium free from extracellular matrix, wherein the cell structure contains cells constituting the st...
|
|
WO/2024/032512A1 |
The present invention relates to the technical field of reverse transcriptase mutants, and specifically, to a reverse transcriptase, a nucleic acid molecule, and a method for synthesizing a cDNA. By introducing mutations into the amino a...
|
|
WO/2024/032360A1 |
The present invention relates to the technical field of veterinary biological products, and specifically, to a lumpy skin disease virus strain, an inactivated vaccine prepared from the strain, and a method for preparing the vaccine. The ...
|
|
WO/2024/035336A1 |
The invention relates to a method of producing a Jasmonate using a fungal cell wherein the expression of the polyketide synthase (PKS) gene has been disrupted in the fungal cell. In one embodiment, the fungal cell is yeast cell Malassezi...
|
|
WO/2024/031835A1 |
Provided is use of Dendrobium officinale DoObgC and a variable spliceosome thereof in promoting embryonic axis elongation. The serial number of the Dendrobium officinale DoObgC nucleotide is KT359612.1. Also provided is a variable splice...
|
|
WO/2024/029760A1 |
Provided are makgeolli (Korean rice wine) and a preparation method therefor, wherein the makgeolli contains fermented pear and decreases in the astringent taste caused by fermentation while offering a fragrant flavor with a unique savory...
|
|
WO/2024/029253A1 |
A homologous recombination method for deleting a specific DNA sequence from a DNA molecule, said method comprising: preparing a DNA molecule in which a pair of target sequences, which are the targets of a site-specific recombinase, are p...
|
|
WO/2024/026923A1 |
Provided is a method for synthesis and assembly and functional test of artificial Chlamydomonas reinhardtii chloroplast genome. Full artificial synthesis of the Chlamydomonas reinhardtii chloroplast genome is proposed based on rational d...
|
|
WO/2024/029242A1 |
Disclosed is a linear peptide or cyclic peptide having an amino acid sequence represented by formula (1): XN-X5-X6-X7-X8-X9-X10-X11-X12-X13-X14-X15 (1), or a pharmacologically acceptable salt thereof. Binding this peptide to LRP1 makes i...
|
|
WO/2024/030355A2 |
A system for casting pig iron is provided. The system has a runner, a tundish, and a mold receiving molten iron in a superheated state, and a feed system positioned adjacent to one of the runner, the tundish, and the mold. The feed syste...
|
|
WO/2024/029930A1 |
According to the present invention, a high-quality polyhydroxyalkanoate resin having excellent color quality can be reliably produced by monitoring the color value during the process of purifying a crude solution containing polyhydroxyal...
|
|
WO/2024/028764A1 |
The present invention relates to the Lacticaseibacillus rhamnosus DSM 33960 bacterial strain, and its use in a method for the prevention and treatment of conditions of dysbiosis of the female urogenital tract, preferably vaginal dysbiosis
|
|
WO/2024/029950A1 |
The present invention relates to a one-step sample pretreatment method for rapid quantitative testing of oral bacteria. Specifically, to perform simple and rapid bacterial analysis on site, a pretreatment method enabling qPCR to be perfo...
|
|
WO/2024/029670A1 |
The present invention relates to a novel Lactobacillus sp. strain, a culture solution thereof and a body fat reduction composition comprising same, and, specifically, to: a novel Lactobacillus helveticus strain; a culture solution thereo...
|
